CompletedPhase 2

Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome

Egypt60 participantsStarted 2019-08-10

Plain-language summary

The aim of the study is to find out the benefit of the platelet-rich plasma in preventing reformation of intrauterine adhesions after adhesiolysis in cases of Asherman syndrome

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Severe intrauterine synechia confirmed by hysteroscopy * age group from 20 to 40 years Exclusion Criteria: * Hemoglobin less than 11 g/dl * Platelet less than 150000/mm3 * Patients taking anticoagulants * Patients taking NSAID in the 15 days prior to the procedure * Active cervical or uterine infection

What they're measuring

Grade of intrauterine adhesions

Timeframe: after one month

Trial details

NCT IDNCT04308811

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-02-20

View on ClinicalTrials.gov More Intrauterine Adhesion trials